Table 5 Patient characteristics on admission by prognostic outcome

Item

Survivors (n = 13)

Non-survivors (n = 8)

p

Age

69.4 (8.9)

74.9 (9.3)

0.193

BMI (kg/m²)

22.3 (3.5)

22.5 (1.7)

0.872

β-DG (pg/ml)

93.8 (161)

82 (64.2)

0.846

KL-6 (U/ml)

771 (461)

1588 (1417)

0.104

LDH (IU/l)

521 (276)

799 (329)

0.051

CRP (mg/dl)

8.22 (4.35)

9.62 (4.92)

0.502

Alb/BUN

0.211 (0.133)

0.119 (0.054)

0.078

Lymphocytes (/μl)

1203 (1011)

752 (389)

0.28

Neutrophils (/μl)

7181 (3012)

7511 (3083)

0.825

WBC (/μl)

9323 (3581)

8700 (3103)

0.7

Interval from admission to PCP diagnosis (days)

4 (2.83)

7.88 (3.56)

0.012

Interval from admission to start PCP-specific treatment (days)

1.77 (2.74)

6.88 (4.67)

0.005